Gujarat Themis Biosyn506879Board meeting scheduled
Board meeting on 4 November 2026 to approve unaudited standalone and consolidated Q2/H1 results
The Board of Directors is scheduled to meet on Wednesday, 4th November, 2026.
By ScoutQuest · · 1 min read
- Board Meeting Date
- Wednesday, 4th November, 2026
- Period Covered
- quarter and half year ended 30th September, 2026
- Trading Window Closure
- closed from 01st October, 2026; reopens 48 hours after the results are published
What the notice says
- Gujarat Themis Biosyn has informed BSE and NSE that a meeting of its Board of Directors is scheduled for Wednesday, 4th November, 2026.
- The Board will consider and approve the Un-Audited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September, 2026.
- The Limited Review Reports of the Auditor on those results will also be placed before the Board.
Trading window cue
- Under the company's Code of Conduct for Prevention of Insider Trading, Designated Persons were intimated that the Trading Window remains closed from 01st October, 2026.
- The window opens only after the expiry of 48 hours from the date of publication of the financial results.
- In simple terms, people who are likely to know the numbers early are restricted from trading in the shares until the results are public and a short cooling-off period has passed.
What this means for a retail investor
- This is a calendar notice: it tells you when the company's second-quarter numbers for the financial year are due, not how the business performed.
- The results will cover both the quarter and the half year ended 30th September, 2026, given both on a standalone and a consolidated basis, with the auditor's limited review attached.
- Until those results are published, there are no performance figures in this intimation to work with.
What to watch on the day
- The standalone and consolidated revenue and profit figures for the quarter and half year.
- Any commentary the company gives around the results, which usually carries more meaning than a single quarter's number.
The notice itself is procedural in nature. The financial detail investors are waiting for will come with the results update.
Also from Gujarat Themis Biosyn
Gujarat Themis Biosyn to hold Investor & Analyst Meet on 5th November 2026 for Q2 & H1 FY27 results
27 Oct 2026
Members Approve Dividend of Re. 0.67 per Share, Preferential Issue of Equity Shares and Amendment to Articles
30 Sep 2026
More numbers
- Trading window reopens after expiry of48 hours
Source: BSE · 27 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.